Related Experiment Video
Updated: Jun 28, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Two siblings with a homozygous MTHFR C677T (G80A-RFC1) mutation and stroke
Massimo Barbagallo1, Piero Pavone, Gemma Incorpora
1Department of Pediatrics, University of Catania, Catania, Italy.
Insights
Childhood stroke can be linked to MTHFR gene mutations. This study identifies a family with multiple arterial ischemic stroke (AIS) patients who have homozygous MTHFR C677T mutations but lack hyperhomocysteinemia.
Area of Science:
- Genetics
- Neurology
- Pediatrics
Background:
- Childhood stroke (arterial ischemic stroke - AIS) is uncommon.
- Methylenetetrahydrofolate reductase (MTHFR) gene C677T mutations are potential risk factors, often associated with hyperhomocysteinemia.
Observation:
- A family with two brothers diagnosed with AIS was studied.
- One sibling presented at age 4 with neurological deficits; his older brother had died at age 7 from AIS.
- Genetic analysis revealed homozygous MTHFR gene C677T (G80A-RFC1) mutations in affected siblings and a healthy older brother, with heterozygous mutations in parents.
Findings:
- This is the first reported family with multiple AIS patients carrying homozygous MTHFR gene C677T (G80A-RFC1) mutations.
- Crucially, none of the affected family members exhibited hyperhomocysteinemia, a condition typically linked to MTHFR mutations and vascular damage.
Implications:
- The findings challenge the established role of hyperhomocysteinemia as the sole mediator of vascular damage in MTHFR C677T-associated stroke.
- Further research is needed to elucidate alternative pathogenic mechanisms for stroke in individuals with these specific MTHFR mutations.
Background:
Stroke is a rare disorder in childhood; among its risk factors, C677T mutations in the methylenetetrahydrofolate reductase (MTHFR) gene with secondary hyperhomocysteinemia are considered.
Patients And Methods:
We report on a family in which two brothers had arterial ischemic stroke (AIS). One of these siblings came to our observation at the age of 4 years because of decreased motility of the right arm, mild hypotrophy of the right limbs, and frequent falls: brain magnetic resonance imaging revealed a large left AIS. Family history revealed that his older brother had died at the age of 7 due to AIS. An extensive metabolic investigation revealed a homozygous C677T [G80A-reduced folate carrier 1 (RFC1)] mutation in the MTHFR gene in both the affected siblings and in their healthy older brother and heterozygous mutations in the parents. None of these family members presented hyperhomocysteinemia.
Conclusions:
To the best of our knowledge, this is the first family with multiple AIS patients harboring homozygous MTHFR gene C677T (G80A-RFC1) mutations without associated hyperhomocysteinemia (the latter factor is usually considered as effector of vascular damage in patients with MTHFR C677T mutations). The pathogenic hypotheses of stroke in this family are considered.
More Related Videos
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Genetic Lingo
Ischemic Stroke ll: Pathophysiology
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Ischemic Stroke l: Introduction